Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component.

Kudgus RA, Walden CA, McGovern RM, Reid JM, Robertson JD, Mukherjee P.

Sci Rep. 2014 Jul 11;4:5669. doi: 10.1038/srep05669.

2.

Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics.

Kudgus RA, Szabolcs A, Khan JA, Walden CA, Reid JM, Robertson JD, Bhattacharya R, Mukherjee P.

PLoS One. 2013;8(3):e57522. doi: 10.1371/journal.pone.0057522. Epub 2013 Mar 6.

3.

Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles.

Arvizo RR, Miranda OR, Moyano DF, Walden CA, Giri K, Bhattacharya R, Robertson JD, Rotello VM, Reid JM, Mukherjee P.

PLoS One. 2011;6(9):e24374. doi: 10.1371/journal.pone.0024374. Epub 2011 Sep 13.

4.

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.

Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, Ames MM, Limburg PJ; Cancer Prevention Network.

Cancer Prev Res (Phila). 2011 Mar;4(3):347-53. doi: 10.1158/1940-6207.CAPR-10-0313.

5.

Case report 620. Progressive systemic sclerosis (PSS) with paraspinous and intraspinous calcifications.

Walden CA, Gilbert P, Rogers LF, Hendrix RW.

Skeletal Radiol. 1990;19(5):377-8.

PMID:
2377907
6.

CT evaluation of adult epiglottitis.

Walden CA, Rogers LF.

J Comput Assist Tomogr. 1989 Sep-Oct;13(5):883-5.

PMID:
2778147
7.

Effects of acute nerve compression on conduction of impulse trains of increasing frequency.

Jewett DL, Walden CA, Chimento TC Jr, Morris JH.

J Neurol Sci. 1985 Feb;67(2):187-99.

PMID:
3981219

Supplemental Content

Loading ...
Support Center